SUBCUTANEOUS INJECTION OF FACTOR-IX FOR THE TREATMENT OF HEMOPHILIA-B

被引:26
作者
GERRARD, AJ
AUSTEN, DEG
BROWNLEE, GG
机构
[1] UNIV OXFORD,SIR WILLIAM DUNN SCH PATHOL,CHEM PATHOL UNIT,S PARKS RD,OXFORD OX1 3RE,ENGLAND
[2] CHURCHILL HOSP,OXFORD HAEMOPHILIA CTR,OXFORD OX3 7LJ,ENGLAND
关键词
D O I
10.1111/j.1365-2141.1992.tb03001.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Haemophilia B patients are normally treated, either prophylactically or in response to bleeding episodes, by frequent intravenous injections of factor IX purified from blood donors. Here we show in model animal experiments that purified human factor IX, when injected subcutaneously, is rapidly (in 3-11 h) and reasonably efficiently (30-40% of an equivalent intravenous dose) transported at least partly by the lymphatic drainage of the skin into the bloodstream, mostly in a biologically active form. This suggests that patients could be treated prophylactically by subcutaneous rather than intravenous injection, where the short delay in raising plasma factor IX to haemostatic levels would be clinically acceptable. More generally, our studies emphasize that the subcutaneous route of injection should be useful for other therapeutic proteins, including other clotting factors, which have to be delivered to the bloodstream, as long as their half-life is at least a few hours allowing time for transport into the general circulation.
引用
收藏
页码:610 / 613
页数:4
相关论文
共 17 条
[1]   EXPRESSION OF ACTIVE HUMAN CLOTTING FACTOR-IX FROM RECOMBINANT DNA CLONES IN MAMMALIAN-CELLS [J].
ANSON, DS ;
AUSTEN, DEG ;
BROWNLEE, GG .
NATURE, 1985, 315 (6021) :683-685
[2]  
AUSTEN DEG, 1975, LABORATORY MANUAL BL
[3]   FATE OF PROTHROMBIN AND FACTORS VIII, IX AND X TRANSFUSED TO PATIENTS DEFICIENT IN THESE FACTORS [J].
BIGGS, R ;
DENSON, KWE .
BRITISH JOURNAL OF HAEMATOLOGY, 1963, 9 (04) :532-&
[4]  
BOCCI V, 1990, J BIOL REG HOMEOS AG, V4, P25
[5]  
GARDULF A, 1991, LANCET, V338, P162
[6]   ROUTE OF RE-CIRCULATION OF LYMPHOCYTES IN RAT [J].
GOWANS, JL ;
KNIGHT, EJ .
PROCEEDINGS OF THE ROYAL SOCIETY SERIES B-BIOLOGICAL SCIENCES, 1964, 159 (975) :257-+
[7]  
HEDNER U, 1989, METABOLIC BASIS INHE, P2107
[8]  
HOVIG T, 1968, AM J PATHOL, V53, P355
[9]   ELECTRICALLY ERODIBLE POLYMER GEL FOR CONTROLLED RELEASE OF DRUGS [J].
KWON, IC ;
BAE, YH ;
KIM, SW .
NATURE, 1991, 354 (6351) :291-293
[10]   COAGULATION PROPERTIES OF CANINE THORACIC-DUCT LYMPH [J].
LANGDELL, RD ;
BOWERSOX, LW ;
WEAVER, RA ;
GIBSON, WS .
AMERICAN JOURNAL OF PHYSIOLOGY, 1960, 199 (04) :626-628